Caspofungin versus liposomal amphotericin B for empirical therapy
- PMID: 15675090
Caspofungin versus liposomal amphotericin B for empirical therapy
Comment on
-
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?N Engl J Med. 2004 Sep 30;351(14):1445-7. doi: 10.1056/NEJMe048203. N Engl J Med. 2004. PMID: 15459307 No abstract available.
Similar articles
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675091 No abstract available.
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675094 No abstract available.
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675092 No abstract available.
-
Use of newer antifungal therapies in clinical practice: what do the data tell us?Oncology (Williston Park). 2004 Nov;18(13 Suppl 7):15-23. Oncology (Williston Park). 2004. PMID: 15651178 Review.
-
Modern antifungal therapy for neutropenic fever.Curr Hematol Malig Rep. 2006 Jun;1(2):95-100. doi: 10.1007/s11899-006-0029-0. Curr Hematol Malig Rep. 2006. PMID: 20425338 Review.
Cited by
-
Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1).Turk J Haematol. 2014 Jun;31(2):111-20. doi: 10.4274/tjh.2014.0103. Epub 2014 Jun 10. Turk J Haematol. 2014. PMID: 25035667 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical